Becker's Healthcare August 12, 2022
Hayley DeSilva

New York City-based Oliver Wyman released findings on private equity deals in healthcare based on data from the first half of 2022.

Here are five takeaways from the report:

  1. The amount of private, capital-backed healthcare deals has significantly declined.
  2. There has been a higher level of capital invested in 2022 so far, mainly because of Bain Capital and Hellman & Friedman’s $17 billion buyout of health tech company Athenahealth in the first quarter.
  3. Pharmaceuticals, biotech and health tech have become more popular, with pharmaceuticals and health tech accounting for more than 70 percent of total capital...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Provider, Trends
Related Articles:
Medical Properties Trust commits $75M to bankrupt Steward
Exclusive: General Catalyst-backed Blackwell Security garners $13M
MIT spin-off Rapid Liquid Print raises $7M for 3D printing
Limerick start-up Mavarick AI raises €1.3m pre-seed led by Act VC
UK AI start-up Wayve raises $1bn backed by Nvidia and Microsoft

Share This Article